7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one has been researched along with 2-amino-7-phosphonoheptanoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lam, FF; Ng, ES | 1 |
1 other study(ies) available for 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one and 2-amino-7-phosphonoheptanoic acid
| Article | Year |
|---|---|
Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Dexamethasone; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Freund's Adjuvant; Glutamic Acid; Injections, Intra-Articular; Isoindoles; Knee Joint; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Neurokinin-1; Substance P; Time Factors | 2010 |